BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,328,570 | -59.1% | 470,137 | -59.3% | 0.02% | -57.4% |
| Q2 2023 | $8,136,290 | -52.0% | 1,155,723 | -43.2% | 0.05% | -54.8% |
| Q1 2023 | $16,966,421 | +0.7% | 2,034,343 | +38.6% | 0.10% | -8.8% |
| Q4 2022 | $16,853,857 | +221.1% | 1,468,106 | +252.5% | 0.11% | +178.0% |
| Q3 2022 | $5,248,000 | +1361.8% | 416,526 | +452.7% | 0.04% | +925.0% |
| Q2 2020 | $359,000 | +897.2% | 75,363 | +316.4% | 0.00% | – |
| Q1 2020 | $36,000 | -99.5% | 18,100 | -99.1% | 0.00% | -100.0% |
| Q4 2019 | $7,302,000 | +56.6% | 2,116,417 | +30.0% | 0.07% | +26.3% |
| Q3 2019 | $4,664,000 | +4178.9% | 1,627,785 | +2212.2% | 0.06% | +2750.0% |
| Q2 2013 | $109,000 | – | 70,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |